NCT01853111View on ClinicalTrials.gov

Withdrawal of Immunosuppression in Recipients of Face and Extremity Transplants

PHASE1CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

March 1, 2014

Primary Completion Date

December 20, 2019

Study Completion Date

March 10, 2020

Conditions
Vascularized Composite Allotransplantation
Interventions
BIOLOGICAL

Interleukin-2

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

Beth Israel Deaconess Medical Center

OTHER

lead

Brigham and Women's Hospital

OTHER

NCT01853111 - Withdrawal of Immunosuppression in Recipients of Face and Extremity Transplants | Biotech Hunter | Biotech Hunter